DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Phlow Corp.
Phlow Corp.
Stage unknownRichmond, VAPharmaceuticals
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 rounds
- Jan 31, 2025Form D equity offering · $30.5M (form d sold) · 9 investorsFact SEC EDGAR Form D data sets (quarterly) · “Phlow Corp. filed Form D: $30,527,397 sold of $40,000,000, Pharmaceuticals”
Investors on record
0 edges
No named investor yet.
People
5 officers, 8 directors
- Daniel Maria Hackman Executive Officer sec.gov
- David Maria Ryan Executive Officer sec.gov
- Elizabeth Maria Whalley Executive Officer sec.gov
- Eric Edwards Executive Officer/Director sec.gov
- Robert Maria Demeria Executive Officer sec.gov
- Melinda Hancock Director Fact
- Marshall Summar Director Fact
- Bernard Gupton Director Fact
- Rosemary Gibson Director Fact
- Guido Villax Director Fact
- Thomas O'Malley Director Fact
- Anna Maria Nekoranec Director Fact
- Kerry Ingalls Director Fact
Timeline
1
- Feb 14, 2025Phlow Corp. filed Form D: $30,527,397 sold of $40,000,000, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $30.5M Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $40.0M Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-01-31 Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 9 Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 424 HULL STREET, SUITE 400, RICHMOND, VA, 23224 Feb 14, 2025 Fact SEC EDGAR Form D data sets (quarterly)